Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOLEUCOVORIN vs LEVOMEPROMAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOLEUCOVORIN vs LEVOMEPROMAZINE: Safety Overview

Metric LEVOLEUCOVORIN LEVOMEPROMAZINE
Total FAERS Reports 3,168 3,024
Deaths Reported 421 585
Death Rate 13.3% 19.3%
Hospitalizations 1,413 1,564
Average Patient Age 64.9 yrs 44.1 yrs
% Female Patients 36.1% 47.2%
FDA Approval Date Apr 29, 2011 Approved Prior to Jan 1, 1982
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Discontinued